We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
EPICENTRE Launches MonsterScript™ Reverse Transcriptase
Product News

EPICENTRE Launches MonsterScript™ Reverse Transcriptase

EPICENTRE Launches MonsterScript™ Reverse Transcriptase
Product News

EPICENTRE Launches MonsterScript™ Reverse Transcriptase


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "EPICENTRE Launches MonsterScript™ Reverse Transcriptase"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

EPICENTRE Biotechnologies’ MonsterScript™ Reverse Transcriptase is a processive, thermostable enzyme that completely lacks RNase H activity. The enzyme retains high activity at temperatures >50°C, and produces full-length cDNA greater than 15 Kb from picogram amounts of RNA.

The MonsterScript™ 1st-Strand cDNA Synthesis Kit also includes Betaine to enable improved reverse transcription through regions of difficult secondary structure.

The kit includes both an oligo(dT)-containing and a random nonamer primer, and a potent RNase Inhibitor. First-strand cDNA can be made from picogram amounts of total RNA.

Advertisement